KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Depreciation & Amortization (CF) (2020 - 2025)

Hims & Hers Health's Depreciation & Amortization (CF) history spans 6 years, with the latest figure at $18.1 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 198.5% year-over-year to $18.1 million; the TTM value through Dec 2025 reached $54.5 million, up 218.95%, while the annual FY2025 figure was $54.5 million, 218.95% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $18.1 million at Hims & Hers Health, up from $17.7 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $18.1 million in Q4 2025 and bottomed at $394000.0 in Q1 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $2.4 million (2023), against an average of $4.6 million.
  • The largest annual shift saw Depreciation & Amortization (CF) soared 415.33% in 2021 before it increased 21.6% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $1.6 million in 2021, then rose by 23.31% to $2.0 million in 2022, then soared by 32.24% to $2.7 million in 2023, then surged by 128.03% to $6.1 million in 2024, then soared by 198.5% to $18.1 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Depreciation & Amortization (CF) are $18.1 million (Q4 2025), $17.7 million (Q3 2025), and $10.5 million (Q2 2025).